scholarly article | Q13442814 |
P50 | author | Ling-Zhi Liu | Q59680831 |
Bing-Hua Jiang | Q63561312 | ||
P2093 | author name string | Lin Wang | |
Peng Zhao | |||
Wei Li | |||
Bing-Hua Jiang | |||
Ling-Zhi Liu | |||
Min Wang | |||
Ning Liu | |||
Qing Xu | |||
Xu Qian | |||
Zhu-Mei Shi | |||
P2860 | cites work | Prohibitin Induces the Transcriptional Activity of p53 and Is Exported from the Nucleus upon Apoptotic Signaling | Q24294918 |
Camptothecin induces nuclear export of prohibitin preferentially in transformed cells through a CRM-1-dependent mechanism | Q24297530 | ||
Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1 | Q24316075 | ||
Prohibitin co-localizes with Rb in the nucleus and recruits N-CoR and HDAC1 for transcriptional repression | Q24323389 | ||
Real-time quantification of microRNAs by stem-loop RT-PCR | Q24535510 | ||
MicroRNA-26a/b and their host genes cooperate to inhibit the G1/S transition by activating the pRb protein | Q24601263 | ||
Tumor-specific expression of microRNA-26a suppresses human hepatocellular carcinoma growth via cyclin-dependent and -independent pathways | Q24624119 | ||
Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers | Q24625794 | ||
Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model | Q24655262 | ||
The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo | Q24657924 | ||
Oncomirs - microRNAs with a role in cancer | Q27860773 | ||
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma | Q27860910 | ||
Loss of post-transcriptional regulation of DNMT3b by microRNAs: a possible molecular mechanism for the hypermethylation defect observed in a subset of breast cancer cell lines | Q37696405 | ||
The role of prohibitin in cell signaling. | Q37788816 | ||
MicroRNA-10b induces glioma cell invasion by modulating MMP-14 and uPAR expression via HOXD10. | Q38336556 | ||
Insulin induced phosphorylation of prohibitin at tyrosine 114 recruits Shp1. | Q38353489 | ||
MiR-21 modulates hTERT through a STAT3-dependent manner on glioblastoma cell growth. | Q39329358 | ||
Gliomas display a microRNA expression profile reminiscent of neural precursor cells. | Q39712696 | ||
MicroRNA-27a functions as an oncogene in gastric adenocarcinoma by targeting prohibitin | Q39940332 | ||
Prohibitin and cofilin are intracellular effectors of transforming growth factor beta signaling in human prostate cancer cells | Q40236424 | ||
Prohibitin is required for Ras-induced Raf-MEK-ERK activation and epithelial cell migration | Q40393756 | ||
Hypoxia-inducible factor 1{alpha} is a new target of microphthalmia-associated transcription factor (MITF) in melanoma cells | Q42813169 | ||
Prohibitin interacts with phosphatidylinositol 3,4,5-triphosphate (PIP3) and modulates insulin signaling | Q42832815 | ||
A PCR-based platform for microRNA expression profiling studies | Q43155279 | ||
Endothelial p70 S6 kinase 1 in regulating tumor angiogenesis. | Q53450181 | ||
Differential protein expression in human gliomas and molecular insights. | Q55471500 | ||
MicroRNA signatures in human cancers | Q27860962 | ||
MicroRNAs: genomics, biogenesis, mechanism, and function | Q27861070 | ||
Prohibitins act as a membrane-bound chaperone for the stabilization of mitochondrial proteins. | Q27934000 | ||
The Prohibitins: emerging roles in diverse functions | Q28248077 | ||
The diverse functions of microRNAs in animal development and disease | Q28266193 | ||
microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma | Q28280337 | ||
Ras-Raf signaling needs prohibitin | Q28282450 | ||
MYC stimulates EZH2 expression by repression of its negative regulator miR-26a | Q28291303 | ||
Pathologically decreased miR-26a antagonizes apoptosis and facilitates carcinogenesis by targeting MTDH and EZH2 in breast cancer | Q28295895 | ||
MiR-26a inhibits cell growth and tumorigenesis of nasopharyngeal carcinoma through repression of EZH2 | Q28302211 | ||
Phylogenetic shadowing and computational identification of human microRNA genes | Q28302536 | ||
Ribo-gnome: the big world of small RNAs | Q29615681 | ||
Vi polysaccharide of Salmonella typhi targets the prohibitin family of molecules in intestinal epithelial cells and suppresses early inflammatory responses | Q30448411 | ||
Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial | Q33453675 | ||
Slit2 inhibits glioma cell invasion in the brain by suppression of Cdc42 activity. | Q33574529 | ||
Rescue of paclitaxel sensitivity by repression of Prohibitin1 in drug-resistant cancer cells | Q33664289 | ||
Integrative genome analysis reveals an oncomir/oncogene cluster regulating glioblastoma survivorship | Q33719798 | ||
Identification of novel synergistic targets for rational drug combinations with PI3 kinase inhibitors using siRNA synthetic lethality screening against GBM. | Q33853600 | ||
miR-182 as a prognostic marker for glioma progression and patient survival. | Q33947151 | ||
miR-34a regulates mouse neural stem cell differentiation | Q33998797 | ||
Reduced expression of brain-enriched microRNAs in glioblastomas permits targeted regulation of a cell death gene | Q34017894 | ||
Identification of MMP-9 specific microRNA expression profile as potential targets of anti-invasion therapy in glioblastoma multiforme | Q34207182 | ||
Dysregulated microRNAs affect pathways and targets of biologic relevance in nasal-type natural killer/T-cell lymphoma | Q34216713 | ||
Malignant glioma: genetics and biology of a grave matter. | Q34272357 | ||
Liver-specific deletion of prohibitin 1 results in spontaneous liver injury, fibrosis, and hepatocellular carcinoma in mice | Q34420616 | ||
The mitochondrial PHB complex: roles in mitochondrial respiratory complex assembly, ageing and degenerative disease | Q34536917 | ||
MiR-21 induced angiogenesis through AKT and ERK activation and HIF-1α expression | Q34841931 | ||
Proteomics of gliomas: initial biomarker discovery and evolution of technology | Q35170365 | ||
MiR-145 directly targets p70S6K1 in cancer cells to inhibit tumor growth and angiogenesis | Q35672212 | ||
High miR-26a and low CDC2 levels associate with decreased EZH2 expression and with favorable outcome on tamoxifen in metastatic breast cancer | Q36070061 | ||
Prohibitin-1 maintains the angiogenic capacity of endothelial cells by regulating mitochondrial function and senescence | Q36404944 | ||
AKT signaling in regulating angiogenesis | Q37089915 | ||
Prohibitin regulates TGF-beta induced apoptosis as a downstream effector of Smad-dependent and -independent signaling | Q37146258 | ||
Curcumin analogue CDF inhibits pancreatic tumor growth by switching on suppressor microRNAs and attenuating EZH2 expression | Q37220420 | ||
P433 | issue | 10 | |
P921 | main subject | microRNA | Q310899 |
P304 | page(s) | 804-812 | |
P577 | publication date | 2013-07-22 | |
P1433 | published in | CNS Neuroscience & Therapeutics | Q5013184 |
P1476 | title | MicroRNA-26a promotes tumor growth and angiogenesis in glioma by directly targeting prohibitin | |
P478 | volume | 19 |
Q28269042 | A novel prohibitin-binding compound induces the mitochondrial apoptotic pathway through NOXA and BIM upregulation |
Q46923795 | Association of prohibitin-1 and 2 with oxidative stress in rats with renal interstitial fibrosis |
Q60929868 | Cannabidiol Affects Extracellular Vesicle Release, miR21 and miR126, and Reduces Prohibitin Protein in Glioblastoma Multiforme Cells |
Q91973832 | Circulating miR-141-3p, miR-143-3p and miR-200c-3p are differentially expressed in colorectal cancer and advanced adenomas |
Q92617953 | Diagnostic value of a microRNA signature panel in exosomes for patients with hepatocellular carcinoma |
Q64077453 | Differentiation antagonizing non-protein coding RNA modulates the proliferation, migration, and angiogenesis of glioma cells by targeting the miR-216a/LGR5 axis and the PI3K/AKT signaling pathway |
Q90700351 | Expression profile analysis of antisense long non-coding RNA identifies WDFY3-AS2 as a prognostic biomarker in diffuse glioma |
Q64052645 | Glioma stem cells-derived exosomal miR-26a promotes angiogenesis of microvessel endothelial cells in glioma |
Q34982573 | Low expression levels of microRNA-124-5p correlated with poor prognosis in colorectal cancer via targeting of SMC4. |
Q36561540 | MiR224-3p inhibits hypoxia-induced autophagy by targeting autophagy-related genes in human glioblastoma cells |
Q60111042 | MicroRNA dysregulation in lung injury: the role of the miR-26a/EphA2 axis in regulation of endothelial permeability |
Q49790324 | MicroRNA-26a and Tumor |
Q54094778 | MicroRNA-26a regulates ANXA1, rather than DAL-1, in the development of lung cancer. |
Q42290877 | MicroRNA-26a targets MAPK6 to inhibit smooth muscle cell proliferation and vein graft neointimal hyperplasia |
Q28087391 | Multifaceted role of prohibitin in cell survival and apoptosis |
Q60927782 | Peptidylarginine Deiminases Post-Translationally Deiminate Prohibitin and Modulate Extracellular Vesicle Release and MicroRNAs in Glioblastoma Multiforme |
Q89797048 | Prohibitin 1 in liver injury and cancer |
Q36797902 | Role of MicroRNAs in Malignant Glioma |
Q55253157 | Significance of prohibitin domain family in tumorigenesis and its implication in cancer diagnosis and treatment. |
Q98386355 | Small RNA profiles of HTLV-1 asymptomatic carriers with monoclonal and polyclonal rearrangement of the T-cell antigen receptor γ-chain using massively parallel sequencing: A pilot study |
Q38796729 | The role of microRNA-26a in human cancer progression and clinical application |
Q38862889 | Upregulation of miR-107 Inhibits Glioma Angiogenesis and VEGF Expression |
Search more.